195 related articles for article (PubMed ID: 15858076)
1. Discovery of novel flavin-containing monooxygenase 3 (FMO3) single nucleotide polymorphisms and functional analysis of upstream haplotype variants.
Koukouritaki SB; Poch MT; Cabacungan ET; McCarver DG; Hines RN
Mol Pharmacol; 2005 Aug; 68(2):383-92. PubMed ID: 15858076
[TBL] [Abstract][Full Text] [Related]
2. Identification and functional analysis of common human flavin-containing monooxygenase 3 genetic variants.
Koukouritaki SB; Poch MT; Henderson MC; Siddens LK; Krueger SK; VanDyke JE; Williams DE; Pajewski NM; Wang T; Hines RN
J Pharmacol Exp Ther; 2007 Jan; 320(1):266-73. PubMed ID: 17050781
[TBL] [Abstract][Full Text] [Related]
3. Genetic variability at the human FMO1 locus: significance of a basal promoter yin yang 1 element polymorphism (FMO1*6).
Hines RN; Luo Z; Hopp KA; Cabacungan ET; Koukouritaki SB; McCarver DG
J Pharmacol Exp Ther; 2003 Sep; 306(3):1210-8. PubMed ID: 12829732
[TBL] [Abstract][Full Text] [Related]
4. Complex mechanism underlying transcriptional control of the haplotyped flavin-containing monooxygenase 3 (FMO3) gene in Japanese: different regulation between mutations in 5'-upstream distal region and common element in proximal region.
Shimizu M; Murayama N; Nagashima S; Fujieda M; Yamazaki H
Drug Metab Pharmacokinet; 2008; 23(1):54-8. PubMed ID: 18305374
[TBL] [Abstract][Full Text] [Related]
5. Molecular evolution and balancing selection in the flavin-containing monooxygenase 3 gene (FMO3).
Allerston CK; Shimizu M; Fujieda M; Shephard EA; Yamazaki H; Phillips IR
Pharmacogenet Genomics; 2007 Oct; 17(10):827-39. PubMed ID: 17885620
[TBL] [Abstract][Full Text] [Related]
6. Flavin-containing monooxygenase 3 gene polymorphisms in Turkish population.
Ozhan G; Topal P; Alpertunga B
Toxicol Mech Methods; 2012 Jul; 22(6):461-5. PubMed ID: 22409263
[TBL] [Abstract][Full Text] [Related]
7. Population distribution of human flavin-containing monooxygenase form 3: gene polymorphisms.
Cashman JR; Zhang J; Leushner J; Braun A
Drug Metab Dispos; 2001 Dec; 29(12):1629-37. PubMed ID: 11717182
[TBL] [Abstract][Full Text] [Related]
8. Novel CYP2C9 promoter variants and assessment of their impact on gene expression.
Kramer MA; Rettie AE; Rieder MJ; Cabacungan ET; Hines RN
Mol Pharmacol; 2008 Jun; 73(6):1751-60. PubMed ID: 18310303
[TBL] [Abstract][Full Text] [Related]
9. FMO3 allelic variants in Sicilian and Sardinian populations: trimethylaminuria and absence of fish-like body odor.
D'Angelo R; Esposito T; Calabrò M; Rinaldi C; Robledo R; Varriale B; Sidoti A
Gene; 2013 Feb; 515(2):410-5. PubMed ID: 23266626
[TBL] [Abstract][Full Text] [Related]
10. Two new polymorphisms of the FMO3 gene in Caucasian and African-American populations: comparative genetic and functional studies.
Lattard V; Zhang J; Tran Q; Furnes B; Schlenk D; Cashman JR
Drug Metab Dispos; 2003 Jul; 31(7):854-60. PubMed ID: 12814961
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of human hepatic flavin containing monooxygenase 3 (FMO3) by CCAAT/enhancer-binding protein beta (C/EBPbeta) liver inhibitory and liver activating proteins.
Klick DE; Shadley JD; Hines RN
Biochem Pharmacol; 2008 Jul; 76(2):268-78. PubMed ID: 18555208
[TBL] [Abstract][Full Text] [Related]
12. Interindividual differences of human flavin-containing monooxygenase 3: genetic polymorphisms and functional variation.
Cashman JR; Zhang J
Drug Metab Dispos; 2002 Oct; 30(10):1043-52. PubMed ID: 12228178
[TBL] [Abstract][Full Text] [Related]
13. Human flavin-containing monooxygenase (form 3): polymorphisms and variations in chemical metabolism.
Cashman JR
Pharmacogenomics; 2002 May; 3(3):325-39. PubMed ID: 12052141
[TBL] [Abstract][Full Text] [Related]
14. Haplotype frequency distribution and linkage disequilibrium analysis of single nucleotide polymorphisms at the human FMO3 gene locus.
Hao DC; Sun J; Furnes B; Schlenk D; Hou ZF; Zhang YP; Yang SL; Yang L
Biochem Genet; 2006 Oct; 44(7-8):391-407. PubMed ID: 17096187
[TBL] [Abstract][Full Text] [Related]
15. Targeted sequencing identifies genetic polymorphisms of flavin-containing monooxygenase genes contributing to susceptibility of nicotine dependence in European American and African American.
Zhang TX; Saccone NL; Bierut LJ; Rice JP
Brain Behav; 2017 Apr; 7(4):e00651. PubMed ID: 28413702
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants of flavin-containing monooxygenase 3 (FMO3) in Japanese subjects identified by phenotyping for trimethylaminuria and found in a database of genome resources.
Shimizu M; Koibuchi N; Mizugaki A; Hishinuma E; Saito S; Hiratsuka M; Yamazaki H
Drug Metab Pharmacokinet; 2021 Jun; 38():100387. PubMed ID: 33831674
[TBL] [Abstract][Full Text] [Related]
17. Three novel single nucleotide polymorphisms of the FMO3 gene in a Japanese population.
Shimizu M; Fujita H; Aoyama T; Yamazaki H
Drug Metab Pharmacokinet; 2006 Jun; 21(3):245-7. PubMed ID: 16858129
[TBL] [Abstract][Full Text] [Related]
18. Trimethylaminuria (fish odor syndrome): genotype characterization among Portuguese patients.
Ferreira F; Esteves S; Almeida LS; Gaspar A; da Costa CD; Janeiro P; Bandeira A; Martins E; Teles EL; Garcia P; Azevedo L; Vilarinho L
Gene; 2013 Sep; 527(1):366-70. PubMed ID: 23791655
[TBL] [Abstract][Full Text] [Related]
19. Phenotyping of flavin-containing monooxygenase using caffeine metabolism and genotyping of FMO3 gene in a Korean population.
Park CS; Chung WG; Kang JH; Roh HK; Lee KH; Cha YN
Pharmacogenetics; 1999 Apr; 9(2):155-64. PubMed ID: 10376762
[TBL] [Abstract][Full Text] [Related]
20. Human flavin-containing monooxygenase form 3: cDNA expression of the enzymes containing amino acid substitutions observed in individuals with trimethylaminuria.
Cashman JR; Bi YA; Lin J; Youil R; Knight M; Forrest S; Treacy E
Chem Res Toxicol; 1997 Aug; 10(8):837-41. PubMed ID: 9282831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
